Wei Gao
10Patents
6h-index
32Co-inventors
62Inventor score
Filing activity: Jul 11, 2001 → Dec 15, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9416190B2 | Mesothelin antibodies and methods for eliciting potent antitumor activity | Physics | 20 | Active |
| US9409992B2 | Mesothelin domain-specific monoclonal antibodies and use thereof | Physics | 13 | Active |
| US9409994B2 | High-affinity monoclonal antibodies to glypican-3 and use thereof | Physics | 12 | Active |
| US9803022B2 | Mesothelin domain-specific monoclonal antibodies and use thereof | Physics | 12 | Active |
| US9394364B2 | Human monoclonal antibodies specific for glypican-3 and use thereof | Physics | 10 | Active |
| US7094567B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 10 | Expired |
| US9206257B2 | Human monoclonal antibodies specific for glypican-3 and use thereof | Physics | 5 | Active |
| US7208308B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 0 | Expired |
| US10640571B2 | Human monoclonal antibodies specific for glypican-3 and use thereof | Physics | 0 | Active |
| US7557192B2 | Anti-PRO335 antibodies | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.